Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-28
2000-06-13
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 314045
Patent
active
060750456
ABSTRACT:
The administration of a therapeutically effective amount of melatonin is an effective method for treating paralysis of the extremities caused by cerebral infarction.
REFERENCES:
Maestroni et al., Immunology, 63(3), 465-470 (abstract), 1988.
Chemical & Engineering News, p. 40, "The Biochemically Active Pineal Gland May Be As Important As Any Other", May 1, 1967.
J. Barchas, et al., Nature, vol. 214, pp. 919-920, "Acute Pharmacology of Melatonin", May 27, 1967.
A. Miles, et al., CRC Critical Reviews in Clinical Laboratory Sciences, vol. 25, Issue 3, pp. 231-253, "Melatonin: Perspectives In Laboratory Medicine and Clinical Research", 1987.
R. Reiter, et al., Life Sciences, vol. 60, No. 25, pp. 2255-2271, "Pharmacological Actions Of Melatonin In Oxygen Radical Pathophysiology", 1997.
J.M. Guerrero, et al., J. Pineal Res., vol. 23, pp. 24-31, Melatonin Prevents Increases In Neural Nitric Oxide and Cyclic GMP Production After Transient Brain Ischemia And Reperfusion In The Mongolian Gerbil (Meriones Unguiculatus), 1997.
S. Cho, et al., Brain Research, vol. 755, pp. 335-338, "Melatonin Administration Protects CA1 Hippocampal Neurons After Transient Forebrain Ischemia In Rats", 1997.
M.D. Ginsberg, et al., Stroke, vol. 20, No. 12, pp. 1627-1642, "Rodent Models Of Cerebral Ischemia", Dec., 1989.
H. Manev, et al., The FASEB Journal., vol. 10, pp. 1546-1551, "Increased Brain Damage After Stroke Or Excitotoxic Seizures In Melatonin-Deficient Rats", Nov., 1996.
R.J. Reiter, Acta Neurobiologi.ae butted. Experimentalis, vol. 54 (Suppl.), pp. 31-39, "Pineal Function During Aging: Attenuation Of The Melatonin Rhythm and Its Neurobiological Consequences", 1994.
R.J. Reiter, The FASEB Journal., vol. 9, No. 7, pp. 526-533, "Oxidative Processes And Antioxidative Defense Mechanisms In The Aging Brain", May, 1995.
E.A. Lane, et al., The Journal of Clinical Endocrinology and Metabolism, vol. 61, No. 6, pp. 1214-1216, "Pharmacokinetics Of Melatonin In Man: First Pass Hepatic Metabolism", Dec., 1985.
O. Vakkuri, et al., Life Sciences, vol. 37, pp. 489-495, "Oral Administration And Distribution Of Melatonin In Human Serum, Saliva And Urine", 1985.
M. Aldhous, et al., British Journal of Clinical Pharmacology, vol. 19, No. 4, pp. 517-521, "Plasma Concentrations Of Melatonin In Man Following Oral Absorption Of Different Preparations", Apr., 1985.
F. Waldhauser, et al., Neuroendocrinology, vol. 39, No. 4, pp. 307-313, "Bioavailability Of Oral Melatonin In Humans", Oct., 1984.
P.A. Vitte, et al., Journal of Pineal Research, vol. 5, No. 5, pp. 437-453, "Plasma, Cerebrospinal Fluid, And Brain Distribution Of .sup.14 C-Melatonin In Rat: A Biochemical And Autoradiographic Study", 1988.
D. Le Bars, et al., International Journal of Radiation Applications and Instrumentation Part B, vol. 18, No. 3, pp. 357-362, "Pet And Plasma Pharmacokinetic Studies After Bolus Intravenous Administration Of [.sup.11 C]Melatonin In Humans", 1991.
W.A. Pulsinelli, et al., Stroke, vol. 10, pp. 267-272, "A New Model Of Bilateral Hemispheric Ischemia In The Unanesthetized Rat", 1979.
Borlongan Cesario V.
Nishino Hitoo
Uneyama Hisayuki
Ajinomoto Co. Inc.
Spivack Phyllis G.
LandOfFree
Method of treating paralysis of the extremities caused by cerebr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating paralysis of the extremities caused by cerebr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating paralysis of the extremities caused by cerebr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2069010